3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
1
Patient Satisfaction
1
Neuromuscular Junction Diseases
1
Nervous System Diseases
1
Neoplasms
1
Myasthenia Gravis
1
Muscle Weakness
1
Immune System Diseases
1
COVID-19
1
Autoimmune Diseases of the Nervous System
1
Autoimmune Diseases
1
Interventions
Data Collection
3
Blood Specimen Collection
2
human papillomavirus vaccine, L1 type 16, 18
1
apremilast
1
Watchful Waiting
1
Telemedicine
1
Surveys and Questionnaires
1
Standard of Care
1
Practice Guidelines as Topic
1
Phlebotomy
1
Mycophenolic Acid
1
Methods
1
Mastectomy, Segmental
1
Mammaplasty
1
Interviews as Topic
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Educational Status
1
Early Intervention, Educational
1
Dietary Fiber
1
CT-P13
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Autoimmune Diseases
×
Telemedicine
×
Clear all
NCT05917184
2023-06-23
ADAPT-teleMG
Yale University
Completed
52 enrolled